Medicare Enrolled

Dr. Emanuel Gottenger, M.D.

Urology Physician · Delray Beach, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
5350 W. ATLANTICE AVENUE, Delray Beach, FL 33484
5614964444
Registered in NPPES since 2006
NPI: 1043261548 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gottenger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gottenger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gottenger

Dr. Emanuel Gottenger is an urology physician in Delray Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gottenger performed 11,657 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Gottenger received a total of $13,816 from 62 pharmaceutical and/or device companies across 461 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gottenger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 10% volume in FL $13,816 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 81204 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
11,657
Medicare services
Top 10% in FL for urology physician
Not available
Unique patients (not deduplicated)
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 2,800 $2 $4
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
1,984 $2 $17
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,617 $98 $175
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,036 $71 $125
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
975 $8 $100
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
626 $3 $17
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
344 $126 $240
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
285 $8 $11
PSA test (prostate cancer screening) 271 $18 $68
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
186 $189 $500
Leuprolide acetate (for depot suspension), 7.5 mg 162 $138 $800
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
134 $100 $200
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
97 $39 $150
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
96 $47 $200
Insertion of temporary bladder tube 88 $37 $175
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
86 $8 $225
Simple change of bladder tube 83 $77 $250
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
82 $49 $200
Lower leg neurostimulator electrode insertion
A procedure to place an electrode in the lower leg for neurostimulation therapy.
70 $93 $248
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
69 $11 $35
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
60 $0 $25
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
56 $71 $425
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
54 $27 $80
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
54 $143 $300
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
45 $18 $68
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
41 $19 $80
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
35 $25 $60
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
31 $59 $245
Injection, garamycin, gentamicin, up to 80 mg 27 $2 $25
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
23 $62 $300
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
19 $108 $400
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
19 $25 $300
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
16 $291 $450
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
16 $27 $325
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
16 $159 $500
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
16 $267 $800
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
15 $75 $1,600
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
12 $260 $1,000
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
11 $346 $1,125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
12.4% medium
87.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,816
Total received (2018-2024)
Avg $1,974/year across 7 years
Top 16% in FL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
461
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,239
2023
$1,602
2022
$3,096
2021
$2,653
2020
$912
2019
$1,922
2018
$2,392

Payments by company (2024)

Astellas Pharma US Inc
$187
Dendreon Pharmaceuticals LLC
$151
PROCEPT BioRobotics Corporation
$135
ABBVIE INC.
$113
COLOPLAST CORP
$113
Sumitomo Pharma America, Inc.
$80
Tolmar, Inc.
$78
Blue Earth Diagnostics Limited
$70
Endo USA, Inc.
$45
Laborie Medical Technologies Corp.
$43
Medtronic, Inc.
$37
Antares Pharma, Inc.
$26
PROGENICS PHARMACEUTICALS, INC.
$26
Becton, Dickinson and Company
$26
AstraZeneca Pharmaceuticals LP
$24
Ferring Pharmaceuticals Inc.
$23
Janssen Biotech, Inc.
$22
Ambu Inc.
$21
Teleflex LLC
$18
Top 3 companies account for 38.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$2,056
PROCEPT BioRobotics Corporation
$1,554
Axonics, Inc.
$1,143
NeoTract Inc.
$652
PFIZER INC.
$629
Endo Pharmaceuticals Inc.
$628
Dendreon Pharmaceuticals LLC
$612
Boston Scientific Corporation
$482
TOLMAR Pharmaceuticals, Inc.
$450
Janssen Biotech, Inc.
$448
Blue Earth Diagnostics Limited
$421
BOSTON SCIENTIFIC CORPORATION
$397
Olympus America Inc.
$305
AbbVie, Inc.
$286
Amgen Inc.
$239
ABBVIE INC.
$206
Sumitomo Pharma America, Inc.
$205
Laborie Medical Technologies Corp.
$204
AstraZeneca Pharmaceuticals LP
$193
UroGen Pharma, Inc.
$188
COLOPLAST CORP
$177
Augmenix, Inc.
$157
Terumo Medical Corporation
$142
Janssen Scientific Affairs, LLC
$141
AbbVie Inc.
$132
Antares Pharma, Inc.
$131
Tolmar, Inc.
$121
Avadel Specialty Pharmaceuticals, LLC
$114
Davol Inc.
$104
MEDIVATION FIELD SOLUTIONS LLC
$102
Coloplast Corp
$99
ROCHESTER MEDICAL CORPORATION
$98
C. R. BARD, INC. & SUBSIDIARIES
$97
C. R. Bard, Inc. & Subsidiaries
$75
Bayer HealthCare Pharmaceuticals Inc.
$74
ConvaTec Inc.
$66
Becton, Dickinson and Company
$58
Endo USA, Inc.
$45
ACCORD HEALTHCARE, INC.
$44
Supernus Pharmaceuticals, Inc.
$40
Myriad Genetic Laboratories, Inc.
$37
Medtronic, Inc.
$37
Aytu BioScience, Inc
$35
Ambu Inc.
$33
PROGENICS PHARMACEUTICALS, INC.
$26
180 Medical, Inc.
$25
Metuchen Pharmaceuticals
$25
Myovant Sciences Inc.
$24
Agiliti Surgical, Inc.
$24
Janssen Pharmaceuticals, Inc
$24
Ferring Pharmaceuticals Inc.
$23
Clarus Therapeutics Inc.
$23
Novartis Pharmaceuticals Corporation
$23
UROVANT SCIENCES INC
$20
Acerus Pharmaceuticals Corporation
$19
Teleflex LLC
$18
UROGEN PHARMA, INC.
$17
Allergan, Inc.
$15
Accord Healthcare, Inc.
$15
Allergan Inc.
$14
Mission Pharmacal Company
$13
Medtronic USA, Inc.
$13
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH FLEXITIP · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard InLay Optima Ureteral Stent with HydroGlide Guidewire · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · EDEX · ELIGARD · ERLEADA · EndoSheath Technology · Erleada · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENTLECATH · GLIDESHEATH SLENDER · GREENLIGHT · GentleCath · INTERSTIM · JATENZO · JELMYTO · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Luja Coude · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Cysto-Resection · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Prolaris · Prolia · REZUM · Rezum Generator · SPEEDICATH · SUTENT · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · TITAN · TOVIAZ · UGN Laser Capital · UROLIFT · UroLift · Urocit-K · XARELTO · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an urology physician in Delray Beach?
Compare urology physicians in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians in nearby ZIP areas
101
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gottenger is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gottenger experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Gottenger performed 2,800 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gottenger receive payments from pharmaceutical companies?
Yes. Dr. Gottenger received a total of $13,816 from 62 companies across 461 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gottenger's costs compare to other urology physicians in Delray Beach?
Dr. Gottenger's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gottenger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →